FDA Adverse Event Injury Summary report: N

EXACTECH, INC.

MDR report key: 9666616 · Received February 4, 2020

Report

Report Number
1038671-2020-00032
Event Type
Injury
Date Received
February 4, 2020
Date of Event
January 1, 2020
Report Date
February 4, 2020
Manufacturer
EXACTECH, INC.
Product Code
JDI
PMA / PMN Number
UNK
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE EVALUATION NOTED WC T, HK P, RG V, CF G, EARLY POLYETHYLENE FAILURE IN A MODERN TOTAL HIP PROSTHESIS: A NOTE OF CAUTION, THE JOURNAL OF ARTHROPLASTY (2020), DOI: HTTPS://DOI.ORG/10.1016/J.ARTH.2019.12.043. AS REPORTED BY THE LITERATURE ARTICLE ¿EARLY POLYETHYLENE FAILURE IN A MODERN TOTAL HIP PROSTHESIS¿, THE EXACTECH CONNEXION GXL LINER MAY BE PRONE TO A HIGH RATE OF EARLY FAILURE FROM WEAR AND SEVERE SECONDARY OSTEOLYSIS. REVIEW OF OUR INSTITUTIONAL REGISTRY REVEALED A PREVALENCE OF SHORT TO MID-TERM FAILURES OF ONE SPECIFIC MODERN ACETABULAR POLYETHYLENE LINER COMPONENT, THE EXACTECH CONNEXION GXL. ADDITIONAL INFORMATION WAS REQUESTED FROM THE ARTICLE AUTHORS, HOWEVER; THEY REPLIED THAT NO ADDITIONAL INFORMATION WILL BE MADE AVAILABLE. CONSIDERING THIS INFORMATION IS MULTIFACTORIAL AND SPECIFIC INFORMATION COULD NOT BE REVIEWED, IT IS NOT POSSIBLE TO DRAW A CONCLUSION AS TO THE CAUSE OF THE EVENT. COMPLAINTS REPORTED RELATED TO THE 12 PATIENTS IN TABLE 1 HAVE BEEN SUBMITTED UNDER INDIVIDUAL MDRS. FOR COMPLAINTS RELATED TO THE 22 PATIENTS LISTED IN TABLE 2 (MAUDE SEARCH DATA), EXACTECH WAS ABLE TO DEFINITIVELY MATCH 18 OF THE 22 TO COMPLAINTS WITHIN THE EXACTECH GLOBAL COMPLAINT HANDLING SYSTEM. THE IDENTIFIED COMPLAINTS ARE AS FOLLOWS: PATIENT # (B)(6), COMPLAINT # (B)(4), MDR # 1038671-2012-00042. (B)(6), (B)(4), 1038671-2013-00047. (B)(6), (B)(4), 1038671-2015-00127. (B)(6), (B)(4), 1038671-2016-00371. (B)(6), (B)(4), 1038671-2016-00509. (B)(6), (B)(4), 1038671-2016-00838. (B)(6), (B)(4), 1038671-2018-00276. (B)(6), (B)(4), 1038671-2018-00288. (B)(6), (B)(4), 1038671-2018-00480. (B)(6), (B)(4), 1038671-2018-00607. (B)(6), (B)(4), 1038671-2018-00767. (B)(6), (B)(4), 1038671-2018-00778. (B)(6), (B)(4), 1038671-2018-00828. (B)(6), (B)(4), 1038671-2018-00925. (B)(6), (B)(4), 1038671-2019-00054. (B)(6), (B)(4), 1038671-2019-00266. (B)(6), (B)(4), 1038671-2019-00326. (B)(6), (B)(4), 1038671-2019-00301. (B)(6), (B)(4), 1038671-2019-00281. WHILE THE REMAINING THREE PATIENTS COULD NOT BE DEFINITIVELY MATCHED TO EXISTING COMPLAINTS WITHIN THE EXACTECH COMPLAINTS SYSTEM, A SEARCH OF THE MAUDE DATABASE CONFIRMS THAT ALL EVENTS RELATED TO GXL CONTAINED WITHIN MAUDE WERE REPORTED BY EXACTECH. THEREFORE, IT IS REASONABLE TO CONCLUDE THAT ALL PATIENT EVENTS REPORTED IN TABLE 2 (MAUDE DATA) HAVE BEEN CAPTURED AND REPORTED AS APPROPRIATE BY EXACTECH.

Description of Event or Problem · 1

WC T, HK P, RG V, CF G, EARLY POLYETHYLENE FAILURE IN A MODERN TOTAL HIP PROSTHESIS: A NOTE OF CAUTION, THE JOURNAL OF ARTHROPLASTY (2020), DOI: HTTPS://DOI.ORG/10.1016/J.ARTH.2019.12.043. AS REPORTED BY THE LITERATURE ARTICLE ¿EARLY POLYETHYLENE FAILURE IN A MODERN TOTAL HIP PROSTHESIS¿, THE EXACTECH CONNEXION GXL LINER MAY BE PRONE TO A HIGH RATE OF EARLY FAILURE FROM WEAR AND SEVERE SECONDARY OSTEOLYSIS. REVIEW OF OUR INSTITUTIONAL REGISTRY REVEALED A PREVALENCE OF SHORT TO MID-TERM FAILURES OF ONE SPECIFIC MODERN ACETABULAR POLYETHYLENE LINER COMPONENT, THE EXACTECH CONNEXION GXL. ADDITIONAL INFORMATION WAS REQUESTED FROM THE ARTICLE AUTHORS, HOWEVER; THEY REPLIED THAT NO ADDITIONAL INFORMATION WILL BE MADE AVAILABLE. CONSIDERING THIS INFORMATION IS MULTIFACTORIAL AND SPECIFIC INFORMATION COULD NOT BE REVIEWED, IT IS NOT POSSIBLE TO DRAW A CONCLUSION AS TO THE CAUSE OF THE EVENT. COMPLAINTS REPORTED RELATED TO THE 12 PATIENTS IN TABLE 1 HAVE BEEN SUBMITTED UNDER INDIVIDUAL MDRS. FOR COMPLAINTS RELATED TO THE 22 PATIENTS LISTED IN TABLE 2 (MAUDE SEARCH DATA), EXACTECH WAS ABLE TO DEFINITIVELY MATCH 18 OF THE 22 TO COMPLAINTS WITHIN THE EXACTECH GLOBAL COMPLAINT HANDLING SYSTEM. THE IDENTIFIED COMPLAINTS ARE AS FOLLOWS: PATIENT # (B)(6), COMPLAINT # (B)(4), MDR # 1038671-2012-00042. (B)(6), (B)(4), 1038671-2013-00047. (B)(6), (B)(4), 1038671-2015-00127. (B)(6), (B)(4), 1038671-2016-00371. (B)(6), (B)(4), 1038671-2016-00509. (B)(6), (B)(4), 1038671-2016-00838. (B)(6), (B)(4), 1038671-2018-00276. (B)(6), (B)(4), 1038671-2018-00288. (B)(6), (B)(4), 1038671-2018-00480. (B)(6), (B)(4), 1038671-2018-00607. (B)(6), (B)(4), 1038671-2018-00767. (B)(6), (B)(4), 1038671-2018-00778. (B)(6), (B)(4), 1038671-2018-00828. (B)(6), (B)(4), 1038671-2018-00925. (B)(6), (B)(4), 1038671-2019-00054. (B)(6), (B)(4), 1038671-2019-00266. (B)(6), (B)(4), 1038671-2019-00326. (B)(6), (B)(4), 1038671-2019-00301. (B)(6), (B)(4), 1038671-2019-00281. WHILE THE REMAINING THREE PATIENTS COULD NOT BE DEFINITIVELY MATCHED TO EXISTING COMPLAINTS WITHIN THE EXACTECH COMPLAINTS SYSTEM, A SEARCH OF THE MAUDE DATABASE CONFIRMS THAT ALL EVENTS RELATED TO GXL CONTAINED WITHIN MAUDE WERE REPORTED BY EXACTECH. THEREFORE, IT IS REASONABLE TO CONCLUDE THAT ALL PATIENT EVENTS REPORTED IN TABLE 2 (MAUDE DATA) HAVE BEEN CAPTURED AND REPORTED AS APPROPRIATE BY EXACTECH.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
127390 EXACTECH, INC. GXL LINERS JDI EXACTECH, INC.

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention